Patients were
monitored throughout the trial for the occurrence of adverse events. All
participants and study personnel were blind to the adjunctive treatment
status. The Prince of Wales Hospital Pharmacy Clinical Trials Unit used a
computer generated randomization schedule to assign patients to the
raloxifene-placebo or placebo-raloxifene treatment order conditions.